US Bancorp’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-807,593
Closed -$80.2M 3838
2019
Q3
$80.2M Sell
807,593
-22,544
-3% -$2.14M 0.22% 103
2019
Q2
$76.7M Sell
830,137
-6,635
-0.8% -$630K 0.21% 106
2019
Q1
$78.9M Sell
836,772
-87,119
-9% -$7.62M 0.23% 100
2018
Q4
$59.2M Sell
923,891
-130,472
-12% -$9.63M 0.19% 115
2018
Q3
$94.4M Buy
1,054,363
+74,017
+8% +$6.54M 0.27% 91
2018
Q2
$77.9M Buy
980,346
+150,932
+18% +$12.5M 0.24% 99
2018
Q1
$74M Buy
829,414
+57,907
+8% +$5.56M 0.23% 103
2017
Q4
$80.5M Sell
771,507
-25,580
-3% -$2.89M 0.25% 99
2017
Q3
$116M Buy
797,087
+33,786
+4% +$4.6M 0.37% 70
2017
Q2
$99.1M Buy
763,301
+48,085
+7% +$5.89M 0.33% 79
2017
Q1
$89M Buy
715,216
+37,668
+6% +$4.51M 0.3% 85
2016
Q4
$78.4M Buy
677,548
+17,002
+3% +$1.89M 0.28% 88
2016
Q3
$69M Sell
660,546
-2,252
-0.3% -$244K 0.26% 98
2016
Q2
$65.4M Buy
662,798
+53,072
+9% +$5.49M 0.25% 97
2016
Q1
$61M Buy
609,726
+89,720
+17% +$9.24M 0.24% 98
2015
Q4
$62.3M Buy
520,006
+24,384
+5% +$2.82M 0.25% 97
2015
Q3
$53.6M Buy
495,622
+67,101
+16% +$8.33M 0.22% 101
2015
Q2
$49.6M Buy
428,521
+6,239
+1% +$713K 0.19% 117
2015
Q1
$48.7M Buy
422,282
+14,539
+4% +$1.74M 0.19% 115
2014
Q4
$45.6M Buy
407,743
+8,240
+2% +$869K 0.18% 122
2014
Q3
$37.9M Sell
399,503
-29,553
-7% -$2.67M 0.15% 131
2014
Q2
$36.8M Buy
429,056
+17,576
+4% +$1.34M 0.15% 133
2014
Q1
$28.7M Sell
411,480
-4,802
-1% -$380K 0.12% 153
2013
Q4
$35.2M Buy
416,282
+7,572
+2% +$599K 0.14% 134
2013
Q3
$31.5M Sell
408,710
-12,784
-3% -$896K 0.14% 137
2013
Q2
$24.7M Buy
+421,494
New +$25.4M 0.11% 151

Other funds holding CELG

US Bancorp's CELG Position: Q4 2019 in Review

US Bancorp sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 807,593 shares — an estimated $80.2M sold.

US Bancorp first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $116M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • US Bancorp reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • US Bancorp sold 807,593 Celgene Corp shares in Q4 2019, an estimated $80.2M.
  • US Bancorp first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • US Bancorp's Celgene Corp position peaked at $116M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.